Cyclooxygenase 2 selective agents and upper gastrointestinal disease
Palmer, R.H.
JAMA 283(15): 1961-1962
2000
ISSN/ISBN: 0098-7484 PMID: 10789662 Document Number: 525518
Document emailed within 1 workday
Related Documents
Karateev, A.E. 2014: Selective cyclooxygenase-2 inhibitors and protected nonsteroidal anti-inflammatory agents: two methods for the prevention of iatrogenic complications Klinicheskaia Meditsina 92(8): 54-61Gonzálvez Sánchez, J.A.; Hernández Bravo, M.T.; Cerda Olmedo, G.; Iborra García, R.; Iborra García G [corrected to Iborra García, R.] 1994: Anticholinergic agents with gastrointestinal selectivity: are they really selective? Atencion Primaria 14(10): 1154
O'Sullivan, S.T.; McGreal, G.T.; Reardon, C.M.; Hehir, D.J.; Kirwan, W.O.; Brady, M.P. 1997: Selective endoscopy in management of ingested foreign bodies of the upper gastrointestinal tract: is it safe? International Journal of Clinical Practice 51(5): 289-292
Ayuo, P.O.; Some, F.F.; Kiplagat, J. 2014: Upper Gastrointestinal Endoscopy Findings in Patients Referred with Upper Gastrointestinal Symptoms in Eldoret, Kenya: a Retrospective Review East African Medical Journal 91(8): 267-273
Mieno, K. 1983: Diagnosis of upper gastrointestinal disease Nursing Technique 29(7): 949-955
Hettich, M.; Thomae, K. 1997: Selective cyclooxygenase-2 inhibitor Der Internist 38(10): 1007
Sallam, M.A. 1976: The role of fibroscopy in diagnosis of upper gastrointestinal disease Journal of the Egyptian Medical Association 59(3-4): 305-319
Margolis, D.M.; Saylor, J.L.; Geisse, G.; DeSchryver-Kecskemeti, K.; Harter, H.R.; Zuckerman, G.R. 1978: Upper gastrointestinal disease in chronic renal failure. a prospective evaluation Archives of Internal Medicine 138(8): 1214-1217
Kawai, S. 2002: Recent development of selective cyclooxygenase-2 inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 60(12): 2370-2377
Langman, M.J.S.; Eichler, H.G.; Mavros, P.; Watson, D.J.; Kong, S.X. 2004: Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs International Journal of Clinical Pharmacology and Therapeutics 42(5): 260-266
Sherer, Y.; Bar-Dayan, Y.; Shoenfeld, Y. 1997: Selective inhibitors of cyclooxygenase-2 in upgrade in nonsteroidal anti-inflammatory drugs Harefuah 132(6): 411-416
Jin, X-feng.; Tong, J-lu.; Ran, Z-hua. 2007: Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis Zhonghua Yi Xue Za Zhi 87(28): 1958-1961
Berreta, J.; Kociak, D.; Corti, R.; Morales, G.; Ortiz, M.; Laplacette, M.ía.; Bellido, F.; Romero, G.; Salgado, P.; Tumilasci, O. 2008: Predictors of intrahospitalary mortality in the upper gastrointestinal variceal bleeding due to chronic liver disease treated endoscopically Acta Gastroenterologica Latinoamericana 38(1): 43-50
Kawata, K.; Takeyoshi, I.; Iwanami, K.; Sunose, Y.; Tsutsumi, H.; Ohwada, S.; Matsumoto, K.; Morishita, Y. 2003: The effects of a selective cyclooxygenase-2 inhibitor on small bowel ischemia-reperfusion injury Hepato-Gastroenterology 50(54): 1970-1974
Perotti, G.; Reale, F.; Pianesi, L.; Peschechera, R.; Andrisani, M.C.; Ciavarella, C.; Celi, G.; Maussier, M.L.; Valenza, V. 2004: Combined diagnostic imaging of upper gastrointestinal tract in a patient with dysphagia and suspected gastroesophageal reflux disease (GERD) Rays 29(2): 179-183
Eyre-Brook, I.A.; Lalla, R. 1999: Gastrointestinal surgical workload in the DGH and the upper gastrointestinal surgeon Annals of the Royal College of Surgeons of England 81(1): 37-39
Haque, M.S.; Sugiyama, K.; Taniguchi, T.; Okada, K.; Nakai, Y.; Kitazawa, Y. 1995: The effects of ETB receptor-selective agonist on IOP and blood-aqueous barrier in rabbit eyes: role of cyclooxygenase products Japanese Journal of Ophthalmology 39(4): 360-367
Takeuchi, K.; Suzuki, K.; Yamamoto, H.; Araki, H.; Mizoguchi, H.; Ukawa, H. 1998: Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 49(4): 501-513
Kruse, R.; Ruzicka, T.; Grewe, M. 2003: Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity Acta Dermato-Venereologica 83(3): 183-185
Leonetti, G.; Sampieri, L.; Cuspidi, C.; Terzoli, L.; Rupoli, L.; Fruscio, M.; Gradnik, R.; Zanchetti, A. 1985: Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S243-S245